Assertio Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Assertio Therapeutics's estimated annual revenue is currently $33M per year.
- Assertio Therapeutics's estimated revenue per employee is $228,917
- Assertio Therapeutics's total funding is $42.5M.
Employee Data
- Assertio Therapeutics has 144 Employees.
- Assertio Therapeutics grew their employee count by 0% last year.
Assertio Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Sr. VP Operations | Reveal Email/Phone |
3 | SVP, Commercial Pricing, Analytics, and Distribution | Reveal Email/Phone |
4 | VP, Business Development and Commercial Analytics | Reveal Email/Phone |
5 | Sr. VP, Commercial Operations | Reveal Email/Phone |
6 | VP, Human Resources | Reveal Email/Phone |
7 | VP, Finance | Reveal Email/Phone |
8 | SVP Medical | Reveal Email/Phone |
9 | SVP, General Counsel | Reveal Email/Phone |
10 | SVP, HR & Administration | Reveal Email/Phone |
Assertio Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Assertio Therapeutics?
Assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit. The Assertio mission of advancing patient care is reflected in our three-pillar strategy
keywords:N/A$42.5M
Total Funding
144
Number of Employees
$33M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Assertio Therapeutics News
Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine,.
Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine,.
The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics...
The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34.8M | 144 | 48% | N/A |
#2 | $42.8M | 144 | -4% | N/A |
#3 | $32.5M | 145 | 77% | N/A |
#4 | $23.4M | 147 | -4% | N/A |
#5 | $23.6M | 148 | -7% | N/A |